Literature DB >> 2423459

The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.

S Kozaki, Y Kamata, T Nagai, J Ogasawara, G Sakaguchi.   

Abstract

Six monoclonal antibodies against Clostridium botulinum type E derivative toxin were prepared. Three of the five binding to the heavy chain neutralized the derivative toxin; the other one binding to the light chain did not. Immunoblotting analysis with the monoclonal antibodies showed that the fragment obtained by tryptic digestion consisted of the light chain and part of the heavy chain (H-1 fragment) linked together by a disulfide bond(s) and that the antigenic determinants common between type E and F derivative toxins were located on both the heavy and light chains. The fragment induced by chymotrypsin treatment, like the tryptic fragment, bound to four monoclonal antibodies. The mild tryptic treatment and reduction resulted in separation of the chymotryptic fragment into two smaller fragments corresponding to the light chain and H-1 fragment. These results indicate that H-1 fragment contains the amino-terminal portion of the heavy chain. The monoclonal antibody neutralizing the toxin and probably recognizing the epitope on the carboxyl-terminal portion (H-2 fragment) of the heavy chain effectively competed for binding of 125I-labeled derivative toxin to synaptosomes. Of the two monoclonal antibodies neutralizing the toxin and recognizing the epitopes on H-1 fragment, one partially inhibited binding, but the other did not. This suggests that the binding of 125I-labeled derivative toxin depends mainly on the carboxyl-terminal region of the heavy chain and that interference with binding is not the only means of toxin neutralization.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423459      PMCID: PMC260927          DOI: 10.1128/iai.52.3.786-791.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  The isolation and characterization of acetylcholine-containing particles from brain.

Authors:  V P WHITTAKER
Journal:  Biochem J       Date:  1959-08       Impact factor: 3.857

2.  Molecular construction of Clostridium botulinum type F progenitor toxin.

Authors:  I Ohishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1975-04

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.

Authors:  G Sakaguchi; S Sakaguchi; S Kozaki; S Sugii; I Oishi
Journal:  Jpn J Med Sci Biol       Date:  1974-06

5.  Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.

Authors:  S Kozaki; S Miyazaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

6.  [Antigenic structure of Cl. botulinum types E and F].

Authors:  T I Bulatova; E V Perova
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1970-04

7.  A common subunit structure in Clostridium botulinum type A, B and E toxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

8.  Purification and some properties of Clostridium botulinum type-E toxin.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  Biochim Biophys Acta       Date:  1968-10-21

9.  Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain.

Authors:  S Kozaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

10.  Purification of Clostridium botuliunum type F progenitor toxin.

Authors:  I Oishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1974-12
View more
  18 in total

1.  Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.

Authors:  S Kozaki; A Miki; Y Kamata; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.

Authors:  S Kozaki; J Onimaru; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

4.  Monoclonal antibody to type F Clostridium botulinum toxin.

Authors:  J L Ferreira; M K Hamdy; S G McCay; F A Zapatka
Journal:  Appl Environ Microbiol       Date:  1990-03       Impact factor: 4.792

5.  Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms.

Authors:  F Chen; G M Kuziemko; P Amersdorfer; C Wong; J D Marks; R C Stevens
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.

Authors:  S Kozaki; J Ogasawara; Y Shimote; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

7.  Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.

Authors:  K Tsuzuki; N Yokosawa; B Syuto; I Ohishi; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.

Authors:  M Z Atassi; B Z Dolimbek; M Hayakari; J L Middlebrook; B Whitney; M Oshima
Journal:  J Protein Chem       Date:  1996-10

9.  Pepsin fragmentation of botulinum type E neurotoxin: isolation and characterization of 112, 48, 46, and 16 kD fragments.

Authors:  J A Giménez; B R DasGupta
Journal:  J Protein Chem       Date:  1992-06

10.  Comparative analysis of C3 and botulinal neurotoxin genes and their environment in Clostridium botulinum types C and D.

Authors:  D Hauser; M Gibert; M W Eklund; P Boquet; M R Popoff
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.